Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-1 vs TS-1 plus CDDP in Advanced Gastric Cancer
NCT00150670Phase 3Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Mar 2002
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in gastric cancer (GC), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Mar 2002; status: completed.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00150670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150670.